Literature DB >> 986843

Characteristics of unlimited access to self-administered stimulant infusions in dogs.

M E Risner, B E Jones.   

Abstract

When drug-naive dogs were given unlimited access to response-contingent intravenous infusions of either d-amphetamine, phenmetrazine, or methylphenidate, a regular cycle of drug intake interspersed with periods of voluntary abstinence was seen. During the drug self-administration phases there was a marked increase in locomotor behavior and stereotypy along with a decrease in body weight; the rest periods were characterized by minimal activity. These results are similar to those observed when humans engage in high-dose intravenous abuse of psychomotor stimulants.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 986843

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  Intravenous self-administration of cocaine and norcocaine by dogs.

Authors:  M E Risner; B E Jones
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

2.  Environmental enrichment during development decreases intravenous self-administration of methylphenidate at low unit doses in rats.

Authors:  Kristin M Alvers; Julie A Marusich; Cassandra D Gipson; Joshua S Beckmann; Michael T Bardo
Journal:  Behav Pharmacol       Date:  2012-10       Impact factor: 2.293

Review 3.  How to make a rat addicted to cocaine.

Authors:  David C S Roberts; Drake Morgan; Yu Liu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-28       Impact factor: 5.067

4.  Phentermine self-administration in naive free-feeding and food-deprived rats: a dose response study.

Authors:  M Papasava; G Singer; C L Papasava
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  A multistep general theory of transition to addiction.

Authors:  Pier Vincenzo Piazza; Véronique Deroche-Gamonet
Journal:  Psychopharmacology (Berl)       Date:  2013-08-21       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.